Page last updated: 2024-11-05

indole-3-carbaldehyde

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

indole-3-carbaldehyde: metabolite of tryptophan; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

indole-3-carbaldehyde : A heteroarenecarbaldehyde that is indole in which the hydrogen at position 3 has been replaced by a formyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID10256
CHEMBL ID147741
CHEBI ID28238
SCHEMBL ID56373
MeSH IDM0059353

Synonyms (87)

Synonym
BB 0242392
1h-indole-3-carbaldehyd
beta-indolylaldehyde
brn 0114117
ai3-52407
einecs 207-665-8
nsc 10118
3-formylindole
3-indolecarboxaldehyde
.beta.-indolylaldehyde
indole-3-carboxyaldehyde
3-indolecarbaldehyde
indole-3-aldehyde
nsc10118
3-indolealdehyde
1h-indole-3-carboxaldehyde
indol-3-carboxaldehyde
nsc-10118
1h-indole-3-carbaldehyde
487-89-8
indole-3-carbaldehyde
indole-3-carboxaldehyde ,
C08493
CU-00000000108-1
indole-3-carboxaldehyde, 97%
NCGC00161738-01
3-indolemethanal
I-2200
STK387546
olnjuiskuqqnim-uhfffaoysa-
inchi=1/c9h7no/c11-6-7-5-10-9-4-2-1-3-8(7)9/h1-6,10h
CHEMBL147741 ,
AG-205/01412034
BMSE000645
FT-0652575
bdbm50182880
I0027
AKOS000119898
A7354
unii-7fn04c32uo
5-21-08-00246 (beilstein handbook reference)
7fn04c32uo ,
3-formylindol
A827605
3-formyl-1h-indole
4877-89-8
3-indolylformaldehyde
a-indolylaldehyde
FT-0670335
F0918-0115
FT-0615872
AM1029
SCHEMBL56373
AB00443651-03
PS-5323
DTXSID5060069
3-indole aldehyde
1h-indole-3-aldehyde
indole 3-carboxaldehyde
indol-3-aldehyde
3-formyl indole
indole-3-carboxy-aldehyde
3-formyl-indole
indole-3-carboaldehyde
indol-3-carbaldehyde
AC-23425
mfcd00005622
CHEBI:28238
i3cho
CS-W007376
indole-3-carboxaldehyde, purum, >=98.0% (t)
1228547-52-1
1h-indole-3-carboxaldehde
indol-3-carbaldehyd
b-indolylaldehyde
NCGC00161738-02
Z56785575
HY-W007376
Q27103575
1h-indole-3-carbaldehyde1h-indole-3-carboxaldehyde487-89-8246045-99-8.beta.-indolylaldehydeindole-3-carbaldehydeindole-3-carboxaldehyde57210_fluka129445_aldrichzinc00087959sbb004120bas 07339836c084933
BCP00081
EN300-16816
SB14957
i3ca
A871878
A897853
3-indolylformaldehyde, 3-formylindole, indole-3-carbaldehyde

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" A formula that combined the phytocompounds in the same proportions as in the herbal extract decreased the dosage of each compound required to achieve maximal AR inhibition."( Compounds from Wedelia chinensis synergistically suppress androgen activity and growth in prostate cancer cells.
Chen, HY; Chen, LR; Hsiao, PW; Ke, FC; Lin, EH; Lin, FM; Tsai, MJ, 2007
)
0.34
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
human xenobiotic metaboliteAny human metabolite produced by metabolism of a xenobiotic compound in humans.
bacterial metaboliteAny prokaryotic metabolite produced during a metabolic reaction in bacteria.
marine metaboliteAny metabolite produced during a metabolic reaction in marine macro- and microorganisms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
indolesAny compound containing an indole skeleton.
heteroarenecarbaldehydeAn aldehyde in which a formyl group is located on a heteroarene.
indole alkaloidAn alkaloid containing an indole skeleton.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
indole glucosinolate activation (herbivore attack)320
indole glucosinolate activation (herbivore attack)424
Tryptophan metabolism2342

Protein Targets (4)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Bifunctional dihydrofolate reductase-thymidylate synthaseLeishmania majorIC50 (µMol)2,000.00000.03000.03000.0300AID554310
Cytochrome P450 2A6Homo sapiens (human)IC50 (µMol)79.00000.00443.889510.0000AID1174075
Cytochrome P450 2A6Homo sapiens (human)Ki11.00000.00561.52717.5000AID1174075
Inosine-5'-monophosphate dehydrogenase 2Homo sapiens (human)IC50 (µMol)22.70000.00700.18071.5000AID264067
Pteridine reductase 1Leishmania majorIC50 (µMol)1,100.00002.95002.95002.9500AID554308
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (12)

Processvia Protein(s)Taxonomy
xenobiotic metabolic processCytochrome P450 2A6Homo sapiens (human)
steroid metabolic processCytochrome P450 2A6Homo sapiens (human)
coumarin metabolic processCytochrome P450 2A6Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2A6Homo sapiens (human)
coumarin catabolic processCytochrome P450 2A6Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2A6Homo sapiens (human)
GMP biosynthetic processInosine-5'-monophosphate dehydrogenase 2Homo sapiens (human)
GTP biosynthetic processInosine-5'-monophosphate dehydrogenase 2Homo sapiens (human)
circadian rhythmInosine-5'-monophosphate dehydrogenase 2Homo sapiens (human)
lymphocyte proliferationInosine-5'-monophosphate dehydrogenase 2Homo sapiens (human)
cellular response to interleukin-4Inosine-5'-monophosphate dehydrogenase 2Homo sapiens (human)
'de novo' XMP biosynthetic processInosine-5'-monophosphate dehydrogenase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (12)

Processvia Protein(s)Taxonomy
iron ion bindingCytochrome P450 2A6Homo sapiens (human)
coumarin 7-hydroxylase activityCytochrome P450 2A6Homo sapiens (human)
enzyme bindingCytochrome P450 2A6Homo sapiens (human)
heme bindingCytochrome P450 2A6Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2A6Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2A6Homo sapiens (human)
nucleotide bindingInosine-5'-monophosphate dehydrogenase 2Homo sapiens (human)
DNA bindingInosine-5'-monophosphate dehydrogenase 2Homo sapiens (human)
RNA bindingInosine-5'-monophosphate dehydrogenase 2Homo sapiens (human)
IMP dehydrogenase activityInosine-5'-monophosphate dehydrogenase 2Homo sapiens (human)
protein bindingInosine-5'-monophosphate dehydrogenase 2Homo sapiens (human)
metal ion bindingInosine-5'-monophosphate dehydrogenase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (12)

Processvia Protein(s)Taxonomy
endoplasmic reticulum membraneCytochrome P450 2A6Homo sapiens (human)
cytoplasmic microtubuleCytochrome P450 2A6Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2A6Homo sapiens (human)
cytoplasmCytochrome P450 2A6Homo sapiens (human)
extracellular regionInosine-5'-monophosphate dehydrogenase 2Homo sapiens (human)
nucleusInosine-5'-monophosphate dehydrogenase 2Homo sapiens (human)
cytoplasmInosine-5'-monophosphate dehydrogenase 2Homo sapiens (human)
peroxisomal membraneInosine-5'-monophosphate dehydrogenase 2Homo sapiens (human)
cytosolInosine-5'-monophosphate dehydrogenase 2Homo sapiens (human)
membraneInosine-5'-monophosphate dehydrogenase 2Homo sapiens (human)
secretory granule lumenInosine-5'-monophosphate dehydrogenase 2Homo sapiens (human)
extracellular exosomeInosine-5'-monophosphate dehydrogenase 2Homo sapiens (human)
ficolin-1-rich granule lumenInosine-5'-monophosphate dehydrogenase 2Homo sapiens (human)
cytoplasmInosine-5'-monophosphate dehydrogenase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (50)

Assay IDTitleYearJournalArticle
AID1082885Antimicrobial activity against Phytophthora capsici PCM81 assessed as zoospore germination at 500 ppm at 24 degC for 8 hr 2012Journal of agricultural and food chemistry, Aug-01, Volume: 60, Issue:30
Isolation and identification of secondary metabolites of Clitocybe nuda responsible for inhibition of zoospore germination of Phytophthora capsici.
AID1082884Antimicrobial activity against Phytophthora capsici PCM81 assessed as zoospore germination at 100 ppm at 24 degC for 8 hr2012Journal of agricultural and food chemistry, Aug-01, Volume: 60, Issue:30
Isolation and identification of secondary metabolites of Clitocybe nuda responsible for inhibition of zoospore germination of Phytophthora capsici.
AID1530048Inhibition of Streptococcus pyogenes SrtA deltaN81 mutant expressed in Escherichia coli BL21(DE3) at 100 uM using Abz-LPETA-Dap(Dnp) as substrate preincubated for 10 mins followed by substrate addition measured every min for 2.5 hrs by fluorimetric assay 2019European journal of medicinal chemistry, Jan-01, Volume: 161Identification of potential antivirulence agents by substitution-oriented screening for inhibitors of Streptococcus pyogenes sortase A.
AID1332260Cytotoxicity against mouse BV2 cells assessed as reduction in cell viability at antineuroinflammatory IC50 after 24 hrs in presence of LPS by MTT assay2017Bioorganic & medicinal chemistry letters, 01-15, Volume: 27, Issue:2
Biotransformation of isofraxetin-6-O-β-d-glucopyranoside by Angelica sinensis (Oliv.) Diels callus.
AID674375Cytotoxicity against human Bel7402 cells at 10 uM after 96 hrs by MTT assay2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Alkaloids from the root of Isatis indigotica.
AID1580649Anti-immunosuppressive activity in LPS-activated mouse MDSC assessed as reduction in PD-L1 expression at 20 to 40 uM incubated for 24 hrs by flow cytometry2019Journal of natural products, 11-22, Volume: 82, Issue:11
Diterpenoids and Bisnorditerpenoids from
AID1082883Antimicrobial activity against Phytophthora capsici PCM81 assessed as inhibition of zoospore germination at 500 mg/L at 24 degC for 8 hr 2012Journal of agricultural and food chemistry, Aug-01, Volume: 60, Issue:30
Isolation and identification of secondary metabolites of Clitocybe nuda responsible for inhibition of zoospore germination of Phytophthora capsici.
AID554308Inhibition of Leishmania major PTR12011Journal of medicinal chemistry, Jan-13, Volume: 54, Issue:1
Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase.
AID1332258Antineuroinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induced NO production after 24 hrs in presence of LPS by Griess reaction based assay2017Bioorganic & medicinal chemistry letters, 01-15, Volume: 27, Issue:2
Biotransformation of isofraxetin-6-O-β-d-glucopyranoside by Angelica sinensis (Oliv.) Diels callus.
AID1174075Inhibition of human CYP2A6 in baculovirus-infected insect cell system using coumarin 7 as substrate preincubated for 10 mins by fluorescence assay2014Bioorganic & medicinal chemistry, Dec-01, Volume: 22, Issue:23
Rational design of novel CYP2A6 inhibitors.
AID1101159Fungicidal activity against Cryphonectria parasitica assessed as inhibition of fungal growth at 12.5 ug after 7 days2000Journal of agricultural and food chemistry, Oct, Volume: 48, Issue:10
Isolation and characterization of fungal inhibitors from Epichloë festucae.
AID105067In vitro growth inhibition in MDA-MB-231 cells by crystal violet staining1998Journal of medicinal chemistry, Dec-03, Volume: 41, Issue:25
Methoxy-substituted 3-formyl-2-phenylindoles inhibit tubulin polymerization.
AID101758In vitro growth inhibition in estrogen sensitive MCF-7 cells by crystal violet staining1998Journal of medicinal chemistry, Dec-03, Volume: 41, Issue:25
Methoxy-substituted 3-formyl-2-phenylindoles inhibit tubulin polymerization.
AID674376Cytotoxicity against human Ketr3 cells at 10 uM after 96 hrs by MTT assay2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Alkaloids from the root of Isatis indigotica.
AID1101162Fungicidal activity against Cryphonectria parasitica assessed as inhibition of fungal growth at 100 ug after 7 days2000Journal of agricultural and food chemistry, Oct, Volume: 48, Issue:10
Isolation and characterization of fungal inhibitors from Epichloë festucae.
AID674372Cytotoxicity against human A549 cells at 10 uM after 96 hrs by MTT assay2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Alkaloids from the root of Isatis indigotica.
AID1780506Inverse agonist activity at Gal4-fused human Nurr1 LBD expressed in HEK293T cells co-expressing firefly luciferase assessed as luciferase activity by hybrid reporter gene assay2021Journal of medicinal chemistry, 10-28, Volume: 64, Issue:20
Development and Profiling of Inverse Agonist Tools for the Neuroprotective Transcription Factor Nurr1.
AID1869400Antifungal activity against Penicillium chrysogenum IBWF assessed as reduction in fungal growth at 25 to 50 ug/ml incubated for 16 to 24 hrs by serial dilution assay
AID1869397Antibacterial activity against Staphylococcus aureus ATCC 11632 assessed as reduction in bacterial growth at 25 to 50 ug/ml incubated for 16 to 24 hrs by serial dilution assay
AID1869396Antibacterial activity against Aneurinibacillus migulanus ATCC 9999 assessed as reduction in bacterial growth at 25 to 50 ug/ml incubated for 16 to 24 hrs by serial dilution assay
AID475505Binding affinity to amyloid beta (1 to 42) oligomers by change in fluorescence at 100 uM after 10 mins2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
A chemical screening approach reveals that indole fluorescence is quenched by pre-fibrillar but not fibrillar amyloid-beta.
AID214174Inhibition of Tubulin polymerization by a 40 uM solution of compound1998Journal of medicinal chemistry, Dec-03, Volume: 41, Issue:25
Methoxy-substituted 3-formyl-2-phenylindoles inhibit tubulin polymerization.
AID264067Inhibition of IMPDH22006Bioorganic & medicinal chemistry letters, May-01, Volume: 16, Issue:9
Low molecular weight indole fragments as IMPDH inhibitors.
AID1869398Antibacterial activity against Pseudomonas aeruginosa ATCC 15442 assessed as reduction in bacterial growth at 25 to 50 ug/ml incubated for 16 to 24 hrs by serial dilution assay
AID1082888Nematicidal activity against Meloidogyne incognita (root-knot nematode) juveniles J2 assessed as paralysis after 1 day2012Journal of agricultural and food chemistry, Aug-01, Volume: 60, Issue:30
Nematicidal activity of 2-thiophenecarboxaldehyde and methylisothiocyanate from caper (Capparis spinosa) against Meloidogyne incognita.
AID1101161Fungicidal activity against Cryphonectria parasitica assessed as inhibition of fungal growth at 50 ug after 7 days2000Journal of agricultural and food chemistry, Oct, Volume: 48, Issue:10
Isolation and characterization of fungal inhibitors from Epichloë festucae.
AID1082886Antimicrobial activity against Phytophthora capsici PCM81 assessed as zoospore germination at 1000 ppm at 24 degC for 8 hr 2012Journal of agricultural and food chemistry, Aug-01, Volume: 60, Issue:30
Isolation and identification of secondary metabolites of Clitocybe nuda responsible for inhibition of zoospore germination of Phytophthora capsici.
AID574897Inhibition of Leptosphaeria maculans BoLm assessed as conversion of brassinin to indole-3-carboxaldehyde at 0.30 mM2011Bioorganic & medicinal chemistry, Feb-15, Volume: 19, Issue:4
Brassinin oxidase mediated transformation of the phytoalexin brassinin: structure of the elusive co-product, deuterium isotope effect and stereoselectivity.
AID1894975Anticancer activity against mouse L5178Y assessed as cell growth inhibition by [3H]-thymidine assay relative to control2021European journal of medicinal chemistry, Aug-05, Volume: 220Discovery of cytotoxic natural products from Red Sea sponges: Structure and synthesis.
AID674374Cytotoxicity against human MCF7 cells at 10 uM after 96 hrs by MTT assay2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Alkaloids from the root of Isatis indigotica.
AID1869395Cytotoxicity against human HeLa S3 cells assessed as cell viability incubated for 48 hrs by microscopic analysis
AID674377Cytotoxicity against human HCT8 cells at 10 uM after 96 hrs by MTT assay2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Alkaloids from the root of Isatis indigotica.
AID1869402Antifungal activity against Phytophthora infestans CBS 430.90 assessed as reduction in fungal growth at 25 to 50 ug/ml incubated for 16 to 24 hrs by serial dilution assay
AID1869399Antifungal activity against Rhizomucor miehei assessed as reduction in fungal growth at 25 to 50 ug/ml incubated for 16 to 24 hrs by serial dilution assay
AID674371Antiviral activity against Herpes simplex virus 1 at 10 uM2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Alkaloids from the root of Isatis indigotica.
AID1869403Antifungal activity against Candida albicans ATCC 90028 assessed as reduction in fungal growth at 25 to 50 ug/ml incubated for 16 to 24 hrs by serial dilution assay
AID1174076Inhibition of human CYP2A6 in baculovirus-infected insect cell system using coumarin 7 as substrate incubated for 30 mins prior to substrate addition measured after 10 mins by fluorescence assay2014Bioorganic & medicinal chemistry, Dec-01, Volume: 22, Issue:23
Rational design of novel CYP2A6 inhibitors.
AID475504Binding affinity to amyloid beta (1 to 42) fibrils by change in fluorescence at 100 uM after 10 mins2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
A chemical screening approach reveals that indole fluorescence is quenched by pre-fibrillar but not fibrillar amyloid-beta.
AID360810Inhibition of tyrosin kinase pp60src1995Journal of natural products, Dec, Volume: 58, Issue:12
Chemical constituents of halophilic facultatively anaerobic bacteria, 1.
AID1372698Inhibition of mushroom tyrosinase at 100 uM using tyrosine as substrate pretreated for 5 mins followed by substrate addition measured after 20 mins by ELISA relative to control2018Bioorganic & medicinal chemistry, 01-15, Volume: 26, Issue:2
Characterization of tyrosinase inhibitory constituents from the aerial parts of Humulus japonicus using LC-MS/MS coupled online assay.
AID1250679Inhibition of human 15-LOX1 assessed as conversion of linoleic acid to 13(S)-HpODE at 50 uM after 10 mins by UV analysis2015Journal of medicinal chemistry, Oct-08, Volume: 58, Issue:19
Rational Development of a Potent 15-Lipoxygenase-1 Inhibitor with in Vitro and ex Vivo Anti-inflammatory Properties.
AID674370Antiviral activity against HIV1 infected in 293T cells cotransfected with VSV-G at 10 uM after 48 hrs by ELISA2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Alkaloids from the root of Isatis indigotica.
AID1101160Fungicidal activity against Cryphonectria parasitica assessed as inhibition of fungal growth at 25 ug after 7 days2000Journal of agricultural and food chemistry, Oct, Volume: 48, Issue:10
Isolation and characterization of fungal inhibitors from Epichloë festucae.
AID1082889Nematicidal activity against Meloidogyne incognita (root-knot nematode) juveniles J2 assessed as paralysis after 1 hr2012Journal of agricultural and food chemistry, Aug-01, Volume: 60, Issue:30
Nematicidal activity of 2-thiophenecarboxaldehyde and methylisothiocyanate from caper (Capparis spinosa) against Meloidogyne incognita.
AID554316Inhibition of human DHFR at 500 uM2011Journal of medicinal chemistry, Jan-13, Volume: 54, Issue:1
Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase.
AID1372697Inhibition of mushroom tyrosinase using tyrosine as substrate pretreated for 5 mins followed by substrate addition measured after 20 mins by ELISA2018Bioorganic & medicinal chemistry, 01-15, Volume: 26, Issue:2
Characterization of tyrosinase inhibitory constituents from the aerial parts of Humulus japonicus using LC-MS/MS coupled online assay.
AID674373Cytotoxicity against human BGC823 cells at 10 uM after 96 hrs by MTT assay2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Alkaloids from the root of Isatis indigotica.
AID1869401Antifungal activity against Paecilomyces variotii ETH 114646 assessed as reduction in fungal growth at 25 to 50 ug/ml incubated for 16 to 24 hrs by serial dilution assay
AID554310Inhibition of Leishmania major DHFR2011Journal of medicinal chemistry, Jan-13, Volume: 54, Issue:1
Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase.
AID1894974Anticancer activity against mouse L5178Y assessed as cell growth inhibition by [3H]-thymidine assay2021European journal of medicinal chemistry, Aug-05, Volume: 220Discovery of cytotoxic natural products from Red Sea sponges: Structure and synthesis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (113)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (4.42)18.7374
1990's5 (4.42)18.2507
2000's23 (20.35)29.6817
2010's48 (42.48)24.3611
2020's32 (28.32)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 42.49

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index42.49 (24.57)
Research Supply Index4.75 (2.92)
Research Growth Index5.17 (4.65)
Search Engine Demand Index61.83 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (42.49)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.88%)5.53%
Reviews6 (5.26%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other107 (93.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]